As European Reference Network for AAT deficiency we want to provide you with comprehensive and specialised care for liver involvement associated with this disease.
We are part of the Department of Gastroenterology, Metabolic Diseases and Medical Intensive Care (Medical Dept III) of the University Hospital RWTH Aachen and are also affiliated with the Center for Rare Diseases located at the same University Hospital. Because of that, we are responsible for the care of patients with rare liver diseases and are particularly specialised in alpha1-antitrypsin deficiency. We are carrying out intensive research into this liver disorder and have been chosen as the coordinating center for AAT deficiency by the European liver association (EASL). We also coordinate the care of patients with AAT-deficiency within the European Reference Network that was initiated by the European commission (ERN Rare-Liver). We are collaborating with various patient organisations throughout Europe and departments of pulmonary medicine that also focus on alpha1-antitrypsin deficiency.
With kind regards
Pavel Strnad, MD, PhD – Lead Consultant of Alpha1-Liver Network and Scientific Advisor of the patient advocacy group Alpha1-Deutschland e.V.
Karim Hamesch, MD – Coordinating Study Physician
Alpha1-Antitrypsin-Mangel: PD Dr. Karim Hamesch erhält den ALTA-Award
Priv.-Doz. Dr. med. Karim Hamesch, Oberarzt in der Klinik für Gastroenterologie, Stoffwechselerkrankungen und Internistische Intensivmedizin an der Uniklinik RWTH Aachen, ist einer von zwei jungen…
Study on liver involvement in mild alpha1-antitrypsin deficiency published in "Gastroenterology”
The Alpha1 Team, based in the Clinic for Gastroenterology, Metabolic Diseases and Medical Intensive Care (Medical Clinic III) at the University Hospital RWTH Aachen, which coordinates the European…